MedPath

Effect of Unani drug (shoniz with sirka) on Buthur labanniya (Acne vulgaris)

Phase 2
Conditions
Health Condition 1: L700- Acne vulgaris
Registration Number
CTRI/2020/06/025718
Lead Sponsor
Central Council for Research in Unani MedicineNew Delhi
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1.Clinically stable patients of Buthur labanniya

2.Patients having comedones,papules,pustules,itching and erythema

3.Patients willing to give consent

4.Patients irrespective of gender

5.Patients in the age group of 10 to 40 years

Exclusion Criteria

1.Patients below the age of 10 and above the age of 40

2.Pregnant females

3.Lactating mothers

4.Mentally retarded persons

5.Patients with severe acne

6.Patients on corticosteroid therapy,anticonvulsant therapy or taking oral contraceptives

7.Patients suffering from other concomitant diseases like acne rosacea,acne fulminans,acne necrotica,psoriasis or eczema etc

8.Patients diagnosed of PCOS

9.Patients with diabetes mellitus,chronic kidney disease and chronic liver disease

10.Patients with thyroid disease

11.History of allergy to Benzoyl Peroxide

13.Patients who fail to give consent

14.Patients who have used any anti acne treatment in last 30 days

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath